{"id":207693,"name":"HARMONY BIOSCIENCES","slug":"harmony-biosciences","state":"PA","country":"United States of America","description":"private biosimilars company","totalSpending":700000,"filings":15,"yearlySpending":[{"year":2020,"income":50000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":250000}],"issues":["HCR","TAX"],"firms":["THORN RUN PARTNERS"],"lobbyists":["ANDREW ROSENBERG","BEAU SCHUYLER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["Issues related to the development of therapies for rare diseases.","Issues related to the development of therapies for rare diseases.","Issues related to the development of therapies for rare diseases\nIssues regarding drug pricing.","Issues related to the development of therapies for rare diseases.\nIssues regarding drug pricing.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.","Issues related to the orphan drug tax credit.\nBuild Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 a"],"years":[2020,2021,2022,2023]}